Literature DB >> 11152531

Human papillomavirus infection requires cell surface heparan sulfate.

T Giroglou1, L Florin, F Schäfer, R E Streeck, M Sapp.   

Abstract

Using pseudoinfection of cell lines, we demonstrate that cell surface heparan sulfate is required for infection by human papillomavirus type 16 (HPV-16) and HPV-33 pseudovirions. Pseudoinfection was inhibited by heparin but not dermatan or chondroitin sulfate, reduced by reducing the level of surface sulfation, and abolished by heparinase treatment. Carboxy-terminally deleted HPV-33 virus-like particles still bound efficiently to heparin. The kinetics of postattachment neutralization by antiserum or heparin indicated that pseudovirions were shifted on the cell surface from a heparin-sensitive into a heparin-resistant mode of binding, possibly involving a secondary receptor. Alpha-6 integrin is not a receptor for HPV-33 pseudoinfection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152531      PMCID: PMC114064          DOI: 10.1128/JVI.75.3.1565-1570.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation.

Authors:  C Meyers; M G Frattini; J B Hudson; L A Laimins
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

Review 2.  Cell surface heparan sulfate proteoglycans.

Authors:  M Yanagishita; V C Hascall
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

3.  Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction.

Authors:  T S Baker; W W Newcomb; N H Olson; L M Cowsert; C Olson; J C Brown
Journal:  Biophys J       Date:  1991-12       Impact factor: 4.033

4.  Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells.

Authors:  C Volpers; P Schirmacher; R E Streeck; M Sapp
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

5.  Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

Authors:  R Kirnbauer; F Booy; N Cheng; D R Lowy; J T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

6.  Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate.

Authors:  T Compton; D M Nowlin; N R Cooper
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

7.  Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.

Authors:  R C Rose; W Bonnez; R C Reichman; R L Garcea
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata.

Authors:  J W Kreider; M K Howett; S A Wolfe; G L Bartlett; R J Zaino; T Sedlacek; R Mortel
Journal:  Nature       Date:  1985 Oct 17-23       Impact factor: 49.962

9.  The L2 open reading frame of human papillomavirus type 1a encodes a minor structural protein carrying type-specific antigens.

Authors:  C A Komly; F Breitburd; O Croissant; R E Streeck
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

10.  Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans.

Authors:  M T Shieh; D WuDunn; R I Montgomery; J D Esko; P G Spear
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

View more
  219 in total

1.  DNA-induced structural changes in the papillomavirus capsid.

Authors:  C Fligge; F Schäfer; H C Selinka; C Sapp; M Sapp
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  An amino acid substitution in the coding region of the E2 glycoprotein adapts Ross River virus to utilize heparan sulfate as an attachment moiety.

Authors:  M L Heil; A Albee; J H Strauss; R J Kuhn
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Specific interaction of the envelope glycoproteins E1 and E2 with liver heparan sulfate involved in the tissue tropismatic infection by hepatitis C virus.

Authors:  Fumi Kobayashi; Shuhei Yamada; Shuhei Taguwa; Chikako Kataoka; Satomi Naito; Yoshiki Hama; Hideki Tani; Yoshiharu Matsuura; Kazuyuki Sugahara
Journal:  Glycoconj J       Date:  2012-06-03       Impact factor: 2.916

4.  Further evidence that papillomavirus capsids exist in two distinct conformations.

Authors:  Hans-Christoph Selinka; Tzenan Giroglou; Thorsten Nowak; Neil D Christensen; Martin Sapp
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

5.  Human keratinocyte cultures in the investigation of early steps of human papillomavirus infection.

Authors:  Laura M Griffin; Louis Cicchini; Tao Xu; Dohun Pyeon
Journal:  Methods Mol Biol       Date:  2014

6.  Porcine Circovirus 2 Uses a Multitude of Weak Binding Sites To Interact with Heparan Sulfate, and the Interactions Do Not Follow the Symmetry of the Capsid.

Authors:  Sonali Dhindwal; Bryant Avila; Shanshan Feng; Reza Khayat
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

7.  Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein.

Authors:  Yuanming Zhang; John C Rassa; Maria Elena deObaldia; Lorraine M Albritton; Susan R Ross
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.

Authors:  Katherine M Johnson; Rhonda C Kines; Jeffrey N Roberts; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

Review 9.  Concepts of papillomavirus entry into host cells.

Authors:  Patricia M Day; Mario Schelhaas
Journal:  Curr Opin Virol       Date:  2013-12-14       Impact factor: 7.090

10.  Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor.

Authors:  Chee Wah Tan; Chit Laa Poh; I-Ching Sam; Yoke Fun Chan
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.